Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection

    May 2016 in “ Cell Host & Microbe
    Wei Liu, Ruifeng Yang, Aimee Payne, Rachel M. Schowalter, Megan E. Spurgeon, Paul F. Lambert, Xiaowei Xu, Christopher B. Buck, Jianxin You
    New to Epidermal Growth Factor? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary In this study, human dermal fibroblasts were identified as natural host cells that support productive Merkel cell polyomavirus infection, and the MEK antagonist trametinib was introduced as an effective inhibitor to control the virus.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The document from June 1, 2016, presents a study that identifies human dermal fibroblasts as the target cells for productive infection by Merkel cell polyomavirus (MCPyV), which can lead to Merkel cell carcinoma (MCC), a lethal form of skin cancer. The study found that the virus establishes replication factories within infected cells, with about 15,000 copies of the viral genome per cell detected by qPCR, and maintains infection for up to 20-30 days. The infection process is enhanced by factors such as EGF, FGF, and the GSK3 inhibitor CHIR99021, which activate the WNT/β-catenin signaling pathway and induce MMP genes, suggesting that skin damage from UV radiation and aging could increase susceptibility to MCPyV infection. The study also introduces trametinib as an effective inhibitor of MCPyV infection, indicating that the MAP kinase pathway may be required for MCPyV infection. These findings are significant for understanding the mechanisms of MCPyV infection and developing potential therapeutic strategies against MCPyV-associated MCC. The number of people or samples used in the study was not specified in the provided text.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results